TY  - JOUR
VL  - 69
ID  - discovery10203409
AV  - public
A1  - Stewart, Sarah-Jane
A1  - Pandolfo, Alyssa
A1  - Jani, Yogini
A1  - Moon, Zoe
A1  - Brealey, David
A1  - Enne, Virve
A1  - Livermore, David
A1  - Gant, Vanya
A1  - Brett, Stephen
A1  - HORNE, Robert
SN  - 0066-4804
KW  - rapid molecular diagnostics
KW  -  antibiotic prescribing
KW  - intensive care
KW  -  pneumonia
IS  - 3
UR  - https://doi.org/10.1128/aac.01156-24
Y1  - 2025/03/05/
PB  - American Society for Microbiology
N2  - Rapid molecular diagnostic tests improve antimicrobial stewardship (AMS) by facilitating earlier refinement of antimicrobial therapy. The INHALE trial tested the application of the BioFire FilmArray Pneumonia Panel (Pneumonia Panel) for antibiotic prescribing for hospital-acquired and ventilator-associated pneumonias (HAP/VAP) in UK intensive care units (ICUs). We report a behavioral study embedded within the INHALE trial examining clinicians? perceptions of using these tests. Semi-structured interviews were conducted with 20 ICU clinicians after using the Pneumonia Panel to manage suspected HAP/VAP. Thematic analysis identified factors reinforcing perceptions of the necessity to modify antibiotic prescribing in accordance with test results and doubts/concerns about doing so. While most acknowledged the importance of AMS, the test?s impact on prescribing decisions was limited. Concerns about potential consequences of undertreatment to the patient and prescriber were often more salient than AMS, sometimes leading to ?just-in-case? antibiotic prescriptions. Test results indicating a broad-spectrum antibiotic were unnecessary often failed to influence clinicians to avoid an initial prescription or de-escalate antibiotics early as they considered their use to be necessary to protect the patient and themselves, ?erring on the side of caution.? Some clinicians described cases where antibiotics would be prescribed for a sick patient regardless of test results because, in their opinion, it fits with the clinical picture??treating the patient, not the result.? Our findings illustrate a tension between prescribing guidelines and clinicians? ?mindlines,? characterized by previous experiences. This highlights the need for a ?technology plus? approach, recognizing the challenges clinicians face when applying technological solutions to patient care.
TI  - Guidelines vs Mindlines: A qualitative investigation of how clinicians? beliefs influence the application of rapid molecular diagnostics in intensive care
JF  - Antimicrobial Agents and Chemotherapy
N1  - © 2025 Stewart et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
ER  -